scholarly article | Q13442814 |
P50 | author | Paolo Bonfanti | Q56334013 |
P2093 | author name string | Giuliano Rizzardini | |
Giorgio L Colombo | |||
Sergio Di Matteo | |||
Giovanna Orlando | |||
Laura Carenzi | |||
Massimo Coen | |||
P2860 | cites work | Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients | Q38959219 |
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection | Q39605935 | ||
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects | Q40729054 | ||
The cost of HIV disease in Northern Italy: the payer's perspective | Q43911880 | ||
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infection | Q44509935 | ||
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART. | Q44744113 | ||
Comparison of Markov model and discrete-event simulation techniques for HIV. | Q46103481 | ||
Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. | Q46667493 | ||
The cost effectiveness of combination antiretroviral therapy for HIV disease. | Q52067020 | ||
Providing antiretroviral therapy for HIV infection | Q73614013 | ||
The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States | Q22242768 | ||
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 | ||
Decline in the AIDS and death rates in the EuroSIDA study: an observational study | Q33967061 | ||
A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy | Q35205440 | ||
Cost-effectiveness analysis of initial HIV treatment under Italian guidelines | Q35602604 | ||
Changing health environment: the challenge to demonstrate cost-effectiveness of new compounds | Q36117463 | ||
The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time | Q36712393 | ||
Antiretroviral therapy and management of HIV infection | Q37770721 | ||
A review of mathematical models of HIV/AIDS interventions and their implications for policy | Q37891590 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | Italy | Q38 |
P304 | page(s) | 377-384 | |
P577 | publication date | 2012-09-17 | |
P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
P1476 | title | Cost-effectiveness analysis of HIV treatment in the clinical practice of a public hospital in northern Italy | |
P478 | volume | 8 |
Q26796419 | A narrative review of cost-effectiveness analysis of people living with HIV treated with HAART: from interventions to outcomes |
Q36956535 | Behavioral and clinical characteristics of people receiving medical care for HIV infection in an outpatient facility in Sicily, Italy |
Q37412246 | Cost analysis of initial highly active antiretroviral therapy regimens for managing human immunodeficiency virus-infected patients according to clinical practice in a hospital setting |
Q35111299 | Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation |
Q38759954 | Early Treatment in HIV Patients: A Cost-Utility Analysis from the Italian Perspective |
Q37225380 | Economic evaluation of initial antiretroviral therapy for HIV-infected patients: an update of Italian guidelines |